Fortetropin inhibits disuse muscle atrophy in dogs after tibial plateau leveling osteotomy

OBJECTIVE: To determine if a commercial myostatin reducer (Fortetropin®) would inhibit disuse muscle atrophy in dogs after a tibial plateau leveling osteotomy. DESIGN: A prospective randomized, double-blinded, placebo-controlled clinical trial. ANIMALS: One hundred client-owned dogs presenting for s...

Descripción completa

Detalles Bibliográficos
Autores principales: White, Dana A., Harkin, Kenneth R., Roush, James K., Renberg, Walter C., Biller, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7144988/
https://www.ncbi.nlm.nih.gov/pubmed/32271840
http://dx.doi.org/10.1371/journal.pone.0231306

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7144988/
https://www.ncbi.nlm.nih.gov/pubmed/32271840
http://dx.doi.org/10.1371/journal.pone.0231306

Ejemplares similares